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Objectives: This study was designed to test the hypothesis that spinal cord stimulation (SCS) improves limb salvage in 
patients with inoperable severe leg ischaemia. 
Desfgn: Prospective randomised controlled study with 18 months follow-up. 
Setting: Vascular surgical units in two university hospitals. 
Materials: Atherosclerotic (n = 41) and diabetic (n = 10) patients having chronic leg ischaemia with rest pain and~or 
ischaemic ulcerations due to technically inoperable arterial occlusions. 
Chief outcome measures: Limb salvage and amount of tissue loss within 18 months, pain relief 
Main results: Twenty-five patients were randomized to SCS and 26 to analgesic (control) treatment. Macrocirculatory 
parameters were not different in the two groups during follow-up. Long-term pain relief was observed only in the SCS 
group. At 18 months, limb salvage rates in the SCS and control groups were 62% and 45% (N.s.). Tissue loss was less 
(p = 0.05) in the SCS group. A subgroup analysis of patients without arterial hypertension showed a significantly lower 
amputation rate in the SCS vs the control group. 
Conclusions: SCS provided long-term pain relief but limb salvage at 18 months was not significantly improved by SCS 
in this rather small study. The results suggest hat SCS may reduce amputation levels in patients with severe inoperable 
leg ischaemia nd be most effective in patients without arterial hypertension. 
Key Words: Amputation; Extremity; Ischaemia; Pain; Spinal cord; Stimulation. 
Untreated severe chronic lower limb ischaemia usu- 
ally leads to pain and skin ulcerations and, if the 
patient survives long enough, to gangrene. Revascu- 
larisation procedures, which usually abolish the need 
for amputation in such patients, are occasionally 
impossible to perform or fail due to poor outflow 
conditions. Although amputation may not be imme- 
diately necessary in such patients, 1 long-term limb 
salvage is poor. ~4 Several conservative treatment 
modalities have been tried in inoperable patients with 
severe lower limb ischaemia. 4'~7 Electrical spinal cord 
stimulation (SCS) has been reported to reduce ischae- 
mic pain s and improve ulcer healing 9-11 and micro- 
circulation 12-13 in ischaemic limbs. It has been sug- 
gested that SCS reduces tissue loss and improves limb 
salvage in inoperable lower limb ischaemia 
patients. 9'14-16 Limb salvage by SCS is unproven, 
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Materials and Methods 
Patients 
During a 5-year period, patients with severe lower 
limb ischaemia in two vascular centres were evaluated 
for participation i  this study. The inclusion criteria 
were severe chronic (duration more than 2 weeks) 
lower limb ischaemia in atherosclerotic and diabetic 
patients with rest pain and/or ischaemic ulcerations, 
however, since demonstration of such an effect 
requires aprospective randomised study. The primary 
hypothesis to be tested in the present randomised 
study was that SCS, as compared to conservative 
analgesic treatment, reduces the amputation rate 
within 18 months in patients with severe lower limb 
ischaemia considered inoperable due to poor outflow 
conditions. 
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in whom vascular reconstruction was considered 
impossible or had failed due to poor outflow condi- 
tions. Exclusion criteria were rapidly progressing 
ischaemia, gangrene of more than one toe, extensive 
infection and/or extensive non-healing ischaemic 
ulcerations, poor cooperability, or presence of asso- 
ciated diseases prohibiting the use of SCS. All patients 
had undergone digital subtraction arteriography. 
Arterial bypass was performed down to the ankle 
level during the first 3 years of the studs~ and down to 
pedal arteries during the last 2 years. A patient was 
considered inoperable if no outflow arteries were 
observed at or above the above mentioned levels, or if 
angiographically demonstrated outflow arteries at 
exploration were found to be heavily calcified, or if 
femorocrural/pedal bypass was possible but no vein 
was available. The study was approved by the Ethics 
Committee of the University of G6teborg. During the 
study period approximately 1000 patients were oper- 
ated upon for severe lower limb ischaemia t the two 
centres. 
Randomisation, treatment and follow-up 
Patients were randomised to either SCS and peroral 
analgesic treatment (SCS group), or peroral analgesic 
treatment alone (control group). Peroral analgesics 
were prescribed as required by the patient: usually 
with dextropropoxyphen as the first choice and 
opiates as the second. The randomisation was strat- 
ified according to Pocock and Simon 17 for sex, age 
(cut-off point was 70 years), diabetes and ischaemic 
ulceration. Management in the control group included 
pain control by analgesics, and care of ischaemic 
ulcers by a specially assigned nurse. Whenever ele- 
vant, antihypertensive and cardiotropic medications 
were optimised by an internist. 
The patients were scheduled for follow-up visits 
to the out-patient clinic at 2, 6, 12 and 18 months after 
randomisation. A few patients who did not attend 
underwent telephone interviews. Indications for 
amputation were progressive gangrene, intractable 
pain, or extensive infection and/or non-healing 
ulcerations. A decision to amputate was taken by the 
patient and an independent orthopaedic surgeon, who 
also performed the amputation. Limb salvage was 
defined as no amputation, or an amputation on the 
forefoot only. The extent of amputation was classified 
in order of increasing handicap as none (no amputa- 
tion, or minor amputations on the forefoot only), 
moderate (unilateral below knee amputation), or 
major (at or above knee level, or any bilateral 
amputation above ankle level). 
SCS treatment 
In the SCS group, the dorsal epidural space was 
punctured under local anaesthesia, nd a thin multi- 
electrode lead was introduced and manipulated under 
fluoroscopic ontrol until the tip reached the target 
point as assessed by intraoperative electrical stimula- 
tion confirming that paraesthesiae were experienced 
in the ischaemic areas, s The lead was anchored to the 
supraspinal fascia. A subcutaneous pouch was estab- 
lished in the left iliac fossa for the pulse generator 
(Medtronic Quad + Itrel II, Medtronic Inc., Minnea- 
polis, U.S.A.). A subcutaneous extension wire con- 
nected the lead and the pulse generator. Prophylactic 
antibiotic treatment was administered. 8 The patient 
was usually discharged a few days later after external 
telemetric programming of the pulse generator. The 
stimulation parameters generally were: pulse width 
210 /~s, frequency 50 Hz and an intensity (voltage) 
giving comfortable paraesthesiae in the ischaemic 
areas: one amplitude for upright position and one 
lower for bed rest were programmed. The patients 
could start or stop the stimulation as well as switch 
between the two stimulation intensities and were 
encouraged to use the stimulator as often as they 
wished. During follow-up visits, the patients were 
interviewed regarding function of the stimulator, and 
in particular egarding the adequacy of paraesthesiae 
in the ischaemic area. The patients were instructed to 
contact he responsible physician between follow-up 
visits if the paraesthesiae disappeared. 
Parameters measured 
The systolic (SP) and diastolic arm blood pressure, the 
ankle doppler pressure (AP) and/or the systolic toe 
pressure (STP) including distal to brachial pressure 
indices (ABI and/or STPI) were measured at randomi- 
sation and, whenever possible, during follow-up visits 
of unamputated patients. The ischaemic pain was 
assessed using two techniques. The patients were 
asked to describe their degree of pain (dummy 
variables) as slight (1), moderate (2), severe (3), very 
severe (4) or intolerable (5). Furthermore, the patients 
were asked to quantify the pain on the visual analogue 
scale (VAS is) from 0 (no pain) to 100 (maximally 
severe pain). The patients also described their feeling 
of warmth (i.e. skin temperature) in the ischaemic area 
using the VAS from zero (maximally cold) to 100 
(maximally warm). Also these parameters were 
recorded at follow-up visits in unamputated patients 
whenever possible. 
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Statistics 
Our previous open study 9showed a 10% limb salvage 
rate in a historical control group as compared to 80% 
in SCS patients (without partial gangrene prior to 
SCS). The hypothesis to be tested in the present study 
was 25% and 70% limb salvage rates at 18 months in 
the control and SCS groups respectively. A sample size 
of approximately 50 patients was estimated to be 
sufficient (alpha <5% and power >80%). Analysis 
was performed on an intention-to-treat basis. Limb 
salvage was calculated at 2, 6, 12 and 18 months and 
the extent of amputation at 18 months. Changes in 
distal pressures, pain and VAS scores were studied by 
the Wilcoxon signed rank test. Limb salvage was 
analysed using the life table technique. 19 Intergroup 
comparisons were made using Z 2 or Mann-Whitney 
U-tests. Calculations regarding the extent of amputa- 
tions included all patients, regardless of whether they 
survived for 18 months or not. 
Results 
Twenty-five and 26 patients who met the inclusion 
and exclusion criteria were randomised to the SCS and 
control groups, respectively. The two groups were 
Table 1. Patient characteristics at randomisation 
SCS (n = 25) Controls (n = 26) 
Age (years + S.D.) 73 + 12 73 + 12 
Female/male (n) 11/14 12/14 
Ischaemic ulceration present (n) 13 13 
Diabetes (n) 5 5 
Arterial hypertension ( )* 11 13 
Pain (VAS score) 52 + 5 55 _+ 5 
Pain score (1-5) 3.2 + 0.2 3.1 _+ 0.2 
Skin temperature (VAS score) 33 + 4 35 + 3 
ABI in ischaemic limbs 0.36 _+ 0.05 0.39 + 0.05 
Medication (n) with 
Opiates 5 6 
Dextropropoxyphen 16 11 
Paracetamol 6 11 
ASA 2 2 
* Data were missing in three patients. 
similar regarding clinical characteristics (Table 1). 
Most patients (Table 2) had critical limb ischaemia 
according to the recently (1992) published criteria in 
the second European Consensus Document. 2° Three 
patients who were randomised to SCS never received 
SCS treatment. In the first case, the patient received a
cardiac pacemaker shortly after randomisation which 
contraindicated SCS, in the second case, rapid deteri- 
oration occurred after randomisation, while in the 
Table 2. Pressure indices for the two groups 
SCS Controls All 
CLI (% of all) 21 (84) 24 (92) 45 (88) 
ABI 0.33 _+ 0.05 0.37 _+ 0.06 0.35 +_ 
0.04 
STPI 0.08 + 0.02 0.05 _+ 0.01 0.06 ± 
0.01 
Values are means _+ SEM. Abbreviations: ABI, ankle to brachial and 
STPI, systolic toe to brachial pressure index; CLI, critical limb 
ischaemia according to the second European Consensus 
Document. ~° 
third case SCS surgery was delayed due to reasons 
unrelated to the patient. These patients received early 
amputation at 1, 4 and 7 weeks respectively and are 
included in the analyses. One patient was reoperated 
for lead displacement during follow-up. There were 
no infections, or other complications to SCS during 
follow-up. 
Mean VAS scores for skin temperature were 
similar in the two groups at randomisation (Table 1), 
and did not significantly change with time. An 
insignificant increase in ABI with time was observed 
in both groups (Fig. 1). The STPI was higher than the 
baseline value in both groups at 2 months and in the 
SCS group also at 18 months (Fig. 2), but there was no 
significant difference between the two groups. Using 
the VAS, significant long term pain relief was 
observed in the SCS but not in the control group (Fig. 
3). Using the semi-quantitative pain score (1-5), pain 
relief (p < 0.05) was observed throughout follow-up in 
the SCS group, but never in the control group. 
In the SCS-group, nine patients (36%) were 
amputated within 18 months versus 14 (54%) in the 
control group. There were eight deaths in each group. 
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Fig. 1. Change in ankle-brachial index (ABI) during follow-up as 
compared to the randomisation value: control (K]); spinal cord 
stimulation (B). There were no significant changes in either group 
(W~flcoxon rank sum test). 
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Fig. 2. Increase in systolic toe pressure index (STPI) dur ing follow- 
up: control (R); spinal cord stimulation (II). *p < 0.05 vs 
randomisat ion value (Wilcoxon rank sum test). There were too few 
( < 5) observations in the control group at 18 months  for analysis. 
Ten of these 16 non-survivors died after having 
reached amputation as primary endpoint. At 18 
months, there was an insignificantly higher limb 
salvage rate (62% vs.  45%) in the SCS vs the control 
group (Fig. 4). None, moderate and major amputa- 
tions within 18 months were observed in 16, 8 and one 
patient in the SCS group vs 11, 8 and 6 in the control 
group. (p = 0.05, ~2 test). 
Subgroup analysis of amputation rates at 18 
months in patients without arterial hypertension 
surviving and followed for 18 months demonstrated a 
higher (p = 0.045, Mann-Whitney U-test) amputation 
rate in the control group (nine out of 13) as compared 
to the SCS group (three out of 11). Subgroup analysis 
in patients with critical limb ischaemia (Table 2) 
demonstrated that 63% and 33% of the surviving 
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Fig. 3. Change in VAS score for pain dur ing follow-up: control (©); 
spinal cord stimulation (e). There were too few ( < 5) observations 
at 18 months  in the control group for analysis. *p < 0.05; **p < 0.01 
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Fig. 4. Limb salvage rates in SCS and control groups within 18 
months: control (©), spinal cord stimulation (e). N.S. vs .  control 
group. The number  of patients entering each interval is depicted. 
patients were unamputated after 18 months (p = 0.08, 
Mann-Whitney U-test) in the SCS and control groups 
respectively. 
Discussion 
This study includes patients with technically inoper- 
able severe chronic lower limb ischaemia nd, using 
amputation and death as endpoints, evaluates the 
effects of spinal cord stimulation (SCS) and peroral 
analgesics as compared to peroral analgesic treatment 
alone. Limb salvage at 18 months was not significantly 
improved by SCS (62% vs .  45%), but the extent of 
amputations was smaller (p=0.05). Mortality was 
similar in the two groups. During follow-up, there 
was significant long-term pain relief only in the SCS 
group whereas distal perfusion pressures were similar 
in the two groups. Subgroup analysis in patients 
without arterial hypertension showed a decreased 
amputation rate at 18 months in response to SCS. 
The limb salvage rate in the SCS group (62%) was 
slightly lower than postulated in the hypothesis (70%) 
to be tested. Three patients randomised to SCS for 
various reasons did not receive SCS but were included 
in the intention-to-treat analysis. If these patients had 
been excluded, the limb salvage rate at 18 months 
would have been 69.9% in the SCS group. By contrast, 
the limb salvage rate in the control group was 
significantly higher than we expected. It is possible 
that this is partly due to intensified care of ischaemic 
ulcers and optimal adjustment of antihypertensive 
drugs. 
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We performed no microcirculatory assessments in 
this study. No significant macrocirculatory effects by 
SCS were observed in comparison with the control 
group. The trend towards increasing pain relief with 
time in the SCS compared to the control group may 
suggest hat improved blood flow is one mechanism 
explaining the pain relief. SCS is reported to improve 
microcirculatory parameters such as capillary density, 
capillary red blood cell velocity (RBCV) and peak 
RBCV in patients with severely ischaemic legs who 
experience pain relief by SCS (denoted as responders), 
suggesting improved skin blood flow by SCS in 
responders. 16 Transcutaneous oxygen tension 
increases in response to SCS ~ supporting this notion. 
Dooley found arterial dilatation in response to SCS. 21 
Roldan, using Doppler ecordings, observed increased 
maximum speed and a tendency towards normal- 
isation of the pulse wave form in response to SCS in 
limb ischaemia patients. 13 Cardiac output (CO) is 
reported to increase in response to transcutaneous 
nerve stimulation, 22 a method supposed to activate 
mechanisms partially similar to those of SCS. The 
effects of SCS on cardiac output in patients with severe 
lower limb ischaemia is not reported. 
A reduced amputation rate at 18 months in 
response to SCS was observed in this study in patients 
without arterial hypertension. Interestingly, better 
results by SCS in non-hypertensive as compared to 
hypertensive patients were also observed in the study 
of Broseta and associates: 1° six out of 10 hypertensive 
patients were amputated uring SCS treatment, as 
compared to none out of 11 non-hypertensive patients. 
The present study failed to show a significant overall 
improvement in limb salvage by SCS. Based on the 
present results, more than 300 patients would be 
needed to demonstrate a limb-saving effect by SCS 
with the present inclusion and exclusion criteria. 
It can be concluded that SCS gives long-term pain 
relief in patients with severe lower limb ischaemia nd 
that the level of amputation may be lowered by SCS. 
The present results further demonstrate that physio- 
logical ong-term effects of SCS as well as limb salvage 
must be evaluated in randomised controlled studies. 
The present data suggest hat improved limb salvage 
by SCS can be expected in normotensive patients, but 
further prospective randomised studies are needed to 
evaluate the significance of this observation. 
Acknowledgements 
We acknowledge the Swedish National Foundation for Heart and 
Lung Diseases, Tore Nilssons Foundation for Medical Research, and 
Bakken Research Center, Maastricht. 
References 
1 RIVERS SP, VEIWH FJ, ASCER E et al. Successful conservative therapy 
of severe limb-threatening ischemia: The value of non-sym- 
pathectomy. Surgery 1986; 99: 759-762. 
2 HUMPHRIES AW, YOUNG JR, DEWOLFE VG, LAFEVRE FA, BEVEN EG. 
Severe ischemia of lower extremity due to arteriosclerosis 
obliterans. Arch Surg 1963; 87: 191-200. 
3 RUTHERFORD RB. Nonoperative management of chronic periph- 
eral arterial insufficiency. In Rutherford RB, ed. Vascular Surgery. 
Philadelphia: WB Saunders, 1984; 564--565. 
4 SCANDINAVIAN-PoLISH MULTICENTER TRIAL GROUP. A stable prosta- 
cyclin-analogue, Iloprost R in the treatment of ischemic ulcers of 
the lower limb. Eur ] Vasc Surg 1990; 4: 463-467. 
5 FREDENUCCI Oxyg6noth6rapie hyperbare t art6riopathies. J Mal 
Vasc 1985; 10: 166-172. 
6 KIM GE, IBRAHIM IM, IMPARATO AM. Lumbar sympathectomy in 
end stage arterial occlusive disease. Ann Surg 1976; 183: 
157-162. 
7 LASSEN NA, LARSEN OA, SORENSEN AVS et al. Conservative 
treatment of gangrene using mineralocorticoid induced moder- 
ate hypertension. Lancet 1968; 1: 606. 
8 AUGUSTINSSON LE. Epidural spinal electrical stimulation (SCS) in 
chronic pain. PhD Thesis, University of G6teborg, Sweden 
1985. 
9 AUGUSTINSSON LE, CARLSSON CA, HOLM J, JIVEGARD L. Epidural 
electrical stimulation in severe limb ischemia. Pain relief, 
increased blood flow, and a possible limb-saving effect. Ann Surg 
1985; 202: 104-110. 
10 BROSETA J, BARBERA J/DE VERA JA et al. Spinal cord stimulation in 
peripheral arterial disease. A cooperative study. J Neurosurg 
1986; 64: 71-80. 
11 FIUME D, PALOMBI M, SCIASSA V, TAMORRI M. Spinal cord 
stimulation (SCS) in peripheral ischemic pain. PACE 1989; 12: 
698-704. 
12 JACOBS MJHM, JORNING PJG, JosHi SR, KITSLAAR PJEHM, SLAAF 
DW, RENEMAN RS. Epidural spinal cord electrical stimulation 
improves microvascular blood flow in severe limb ischemia. Ann 
Surg 1988; 207: 179-183. 
13 ROLDAN P, JOANES Mr SANTAMARIA I. Hemodynamic changes from 
spinal cord stimulation for vascular pain. Acta Neurochir 1987; 
Suppl 39: 166-169. 
14 J1VEG~RD L, AUGUST1NSSON L-E, CARLSSON C-A, HOLM I. Long- 
term results by epidural spinal electrical stimulation in patients 
with inoperable severe lower limb ischemia. Eur J Vasc S urg 1987; 
1: 345-349. 
15 BRACALE GC, SELVETELLA L, MIRABILE F. Our experience with 
spinal cord stimulation in peripheral vascular disease. PACE 
1989; 12: 695q597. 
16 JACOBS MJHM, JORNING PJG, BECKERS RCY et al. Foot salvage and 
improvement ofmicrovascular blood flow as a result of epidural 
spinal cord electrical stimulation. J Vasc Surg 1990; 12: 354-360. 
17 POCOCK S, SIMON R. Sequential treatment assignment with 
balancing for prognostic factors in the RCT. Biometrics 1975; 31: 
103-115. 
18 HUSKINSSON EC. Measurement of pain. Lancet 1974; 2: 
1127-1131. 
19 HARVALD B, HILDEN % LUND E. Long-term anticoagulant therapy 
after myocardial infarction. Lancet 1962; 2: 626-632. 
20 EUROPEAN WORKING GROUP ON CRITICAL LIMB ISCHAEMIA. Second 
European consensus document on chronic critical eg ischemia. 
Eur J Vasc Surg 1992; 5(Suppl A): 1-32. 
21 DOOLEY DM, KASPRAK M. Modification of blood flow to the 
extremities by electrical stimulation of the nervous ystem. South 
Med J 1976; 69: 1309-1311. 
22 MANNHEIMER C, CARLSSON C-A, EMANUELSSON H, VEDIN A, 
WAAGSTEIN Fr WILHELMSSON C. The effects of transcutaneous 
electrical nerve stimulation in patients with severe angina 
pectoris. Circulation 1985; 71: 308-316. 
Accepted 4 July 1994 
Eur J Vasc Endovasc Surg Vol 9, May 1995 
